| Form | Liquid |
|---|
| Host Species | Human |
|---|
| Clonality | Monoclonal |
|---|
| Isotype | IgG1-kappa |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Concentration | 1mg/ml |
|---|
| Endotoxin Level | Please contact the lab for this information. |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Species Reactivity | Staphylococcus aureus |
|---|
| Target | lukG |
|---|
| Storage Buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Expression System | Mammalian Cells |
|---|
| Accession Number | A0A6B5MC52 |
|---|
| Background | Berlimatoxumab (ASN-2) is an antibody. Berlimatoxumab can be used for experiment research.<br>• Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins., PMID:24586678<br/>• Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity., PMID:31852826<br/>• Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies., PMID:27467113<br/>• Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH., PMID:25371205<br/>• Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories., PMID:35858453<br/>• Human antibody responses against non-covalently cell wall-bound Staphylococcus aureus proteins., PMID:29459694<br/>• Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics., PMID:20661294<br/>• Serum neutralizing antibody after rabies postexposure prophylaxis., PMID:945973<br/>• Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening., PMID:29176494<br/>• Vitamin E regulates mitochondrial hydrogen peroxide generation., PMID:10490278<br/> |
|---|
| Alternative Names | ASN-100(combinationofatidortoxumabandberlimatoxumab), ASN-2, 1939109-24-6 |
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|